ROYALTY PHARMA PLC: Diferență între versiuni

De la TradeVille.ro wiki
(csv2wiki)
 
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).)
 
(Nu s-a afișat o versiune intermediară efectuată de un alt utilizator)
Linia 1: Linia 1:
 
Pagina dedicata companiei ROYALTY [[PHARMA]] PLC listata cu simbolul US.RPRX
Pagina dedicata companiei ROYALTY PHARMA PLC listata cu simbolul US.RPRX


==Descriere companie==
==Descriere companie==
Royalty Pharma plc (https://www.royaltypharma.com) is engaged in investing in late stage biopharmaceutical products. The Company invests in academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The Company’s portfolio of pharmaceutical investment includes investments in commercial products and development-stage product candidates. Its portfolio investments include AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko, Trikafta and OXLUMO.
Royalty Pharma plc (https://www.royaltypharma.com) is engaged in investing in late stage biopharmaceutical products. The Company invests in academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The Company’s portfolio of pharmaceutical investment includes investments in commercial products and development-stage product candidates. Its portfolio investments include AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko, Trikafta and OXLUMO.


==Grafic actiuni companie==
<iframe key="tradeville" path="graficSimbol/US.RPRX" />


==Ultimele stiri despre ROYALTY PHARMA PLC (US.RPRX)==
==Ultimele stiri despre ROYALTY PHARMA PLC (US.RPRX)==
Linia 13: Linia 14:
addfirstcategorydate=false
addfirstcategorydate=false
</dynamicpagelist>
</dynamicpagelist>
[[Categorie:US.RPRX]][[Categorie:Stiri despre companii]]
[[Categorie:US.RPRX]][[Categorie:Stiri despre companii]]

Versiunea curentă din 3 octombrie 2024 05:34

Pagina dedicata companiei ROYALTY PHARMA PLC listata cu simbolul US.RPRX

Descriere companie[edit | ]

Royalty Pharma plc (https://www.royaltypharma.com) is engaged in investing in late stage biopharmaceutical products. The Company invests in academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. The Company’s portfolio of pharmaceutical investment includes investments in commercial products and development-stage product candidates. Its portfolio investments include AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko, Trikafta and OXLUMO.

Grafic actiuni companie[edit | ]

Ultimele stiri despre ROYALTY PHARMA PLC (US.RPRX)[edit | ]